What's in Humanis Saglık Anonim Sirketi's pipeline?

Humanis Saglık Anonim Sirketi has 28 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 26 in Phase 1.

Which companies overlap with Humanis Saglık Anonim Sirketi's portfolio?

Top competitors by shared drug class: Aga Khan University, Ain Shams University, Cinclus Pharma Holding AB, Daewoong Pharmaceutical Co. LTD., Eli Lilly.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/humanis-sagl-k-anonim-sirketi.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Humanis Saglık Anonim Sirketi — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Humanis Saglık Anonim Sirketi pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 26 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Macitentan and Tadalafil	Macitentan and Tadalafil	marketed	Phosphodiesterase 5 Inhibitor [EPC]
Vonoprazan Tablets	Vonoprazan Tablets	marketed	Potassium-competitive acid blocker (P-CAB)	H+/K+-ATPase (proton pump)	Gastroenterology

Therapeutic area mix

Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Aga Khan University · 1 shared drug class
Ain Shams University · 1 shared drug class
Cinclus Pharma Holding AB · 1 shared drug class
Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
Eli Lilly · 1 shared drug class
Vivus Llc · 1 shared drug class
Zhang Xiaofeng,MD · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Humanis Saglık Anonim Sirketi:

Cite this brief

Drug Landscape (2026). Humanis Saglık Anonim Sirketi — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/humanis-sagl-k-anonim-sirketi. Accessed 2026-05-18.